Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Improving blood sugar control during pregnancy for women with type 2 diabetes using technology and coaching

Official title: ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

Run by Ohio State University · NCT05662462 · Data updated 2026-11-12

This study is testing whether using a mobile app and coaching can help pregnant women with type 2 diabetes better control their blood sugar compared to regular prenatal care.

More Type2diabetes trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment124 (estimated)
SponsorOhio State University
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedJuly 11, 2024
Main results expectedMay 2028
Study endsMarch 2029
Registry record updatedJune 29, 2026
Trial IDNCT05662462 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant individuals aged 18 and older with pregestational type 2 diabetes and an A1c of 6.5% or higher, enrolled in Medicaid.

Probably not a fit

Patients who are not pregnant or those with type 2 diabetes not enrolled in Medicaid may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ACHIEVE project aims to enhance glycemic control in pregnant individuals with type 2 diabetes by utilizing a mobile health application, continuous glucose monitoring, and care team coaching. This intervention will be compared to standard prenatal care to assess its effectiveness in achieving a target hemoglobin A1c of less than 6.5% during the third trimester. The study focuses on addressing non-medical social needs that hinder glycemic control, particularly among Medicaid-enrolled participants. By integrating technology and personalized support, the study seeks to empower patients and improve maternal and infant health outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly reduce adverse pregnancy outcomes for women with type 2 diabetes.

How similar studies have gone: Other studies have shown promising results with technology-assisted interventions for diabetes management, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. pregnant individuals age ≥18 years;
2. ≤20 weeks of gestation (specifically, \<20+6 weeks);
3. diagnosis of pregestational T2D and A1c ≥6.5% at the time of study enrollment;
4. Medicaid insurance;
5. English or Spanish speaking;
6. cognitively able to complete the study requirements;
7. consent to all study activities;
8. accessible for participation in study activities;
9. use a smartphone with internet access;

Participants must also consent to the study team abstracting information from their electronic health records (EHRs), using CGM for glucose monitoring if randomized to the intervention group, tracking the participants' clinic, hospital, and emergency room visits during the study period, as well as tracking the number of times the participants use the ACHIEVE mobile health (mHealth) application (app), including what activities are used in the mobile application (e.g., recording blood glucose, scheduling appointments, messaging their healthcare providers, accessing educational resources).

Where it's running

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.